These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6260497)
41. Tc-99m-pertechnetate scanning in metastatic thyroid carcinoma: a case report. Lamberigts G; De Roo M; Devos P; Burie D Clin Nucl Med; 1981 Apr; 6(4):172-4. PubMed ID: 7214773 [TBL] [Abstract][Full Text] [Related]
42. Solitary thyroid nodules. Reschini E; Catania A Lancet; 1985 Nov; 2(8466):1237. PubMed ID: 2866307 [No Abstract] [Full Text] [Related]
43. [Thyroid scintigraphy]. Secades I; Torres M; Arnáiz F; Castell M; La Banda JP Rev Esp Med Nucl; 1999 Jun; 18(3):227-30. PubMed ID: 10475736 [No Abstract] [Full Text] [Related]
44. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide. Scott GC; Meier DA; Dickinson CZ J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053 [TBL] [Abstract][Full Text] [Related]
45. Quantitative differences between the thyroid uptake of 123I and 99mTc. Siegel JA; Harpen MD; Lee WP; Verma RC; Greenfield MA Eur J Nucl Med; 1984; 9(11):494-8. PubMed ID: 6097449 [TBL] [Abstract][Full Text] [Related]
46. Disparate imaging of the autonomous functioning thyroid nodule with 99mTc-pertechnetate and radioiodine. Miller JM; Kasenter AG; Marks DS Radiology; 1976 Jun; 119(3):737-9. PubMed ID: 935420 [TBL] [Abstract][Full Text] [Related]
49. Impact of radiocontaminants in commercially available iodine-123: dosimetric evaluation. Ziessman HA; Fahey FH; Gochoco JM J Nucl Med; 1986 Mar; 27(3):428-32. PubMed ID: 3012027 [TBL] [Abstract][Full Text] [Related]
50. Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with 99mTc-sestamibi and 123I. Caveny SA; Klingensmith WC; Martin WE; Sage-El A; McIntyre RC; Raeburn C; Wolfe P J Nucl Med Technol; 2012 Jun; 40(2):104-10. PubMed ID: 22566587 [TBL] [Abstract][Full Text] [Related]
51. Comparison of 99mTc and 123I for thyroid imaging. Arnold JE; Pinsky S J Nucl Med; 1976 Apr; 17(4):261-7. PubMed ID: 1255250 [TBL] [Abstract][Full Text] [Related]
52. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. Zuckier LS; Dohan O; Li Y; Chang CJ; Carrasco N; Dadachova E J Nucl Med; 2004 Mar; 45(3):500-7. PubMed ID: 15001694 [TBL] [Abstract][Full Text] [Related]
53. Disparate uptake of 99mTcO4- and 125I- in thyroid cells in culture. Eggo MC; Bachrach LK; Mak W; Burrow GN Horm Metab Res; 1986 Mar; 18(3):167-72. PubMed ID: 3009293 [TBL] [Abstract][Full Text] [Related]
54. Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer. Gulzar Z; Jana S; Young I; Bukberg P; Yen V; Naddaf S; Abdel-Dayem HM Endocr Pract; 2001; 7(4):244-9. PubMed ID: 11497474 [TBL] [Abstract][Full Text] [Related]
55. [Scintigraphy of the thyroid gland with technetium 99m pertechnetate]. Pedersen DM; Petersen G; Dyrbye M Ugeskr Laeger; 1986 Jan; 148(3):131-2. PubMed ID: 3006309 [No Abstract] [Full Text] [Related]
56. Evaluation of thyroid scintigraphy in small animals. Kaneko M; Kobayashi T; Takano H; Ohnishi T; Kaku T; Nishi T; Kawase C; Kaneko K Radioisotopes; 1989 Aug; 38(8):344-6. PubMed ID: 2798958 [TBL] [Abstract][Full Text] [Related]